Condition: Trigeminal Neuralgia · Sponsor: Université de Sherbrooke
The aim of this study is to assess the feasibility of deep brain stimulation for refractory trigeminal neuralgia due to a pontine lesion, as is usually seen in the context of multiple sclerosis. These patients usually have severe intractable facial pain and current medical and surgical options generally fail to achieve long lasting pain relief. Hoping to improve pain control in this population, the investigators of this trial propose a novel technique consisting of implanting a deep brain stimulation lead within the pontine lesion to modulate the generation of pain signals.
This description comes directly from the study's public registry record.
Christian Iorio-Morin, MD, PhD, FRCS(C) · 819-346-1110 · Christian.Iorio-Morin@usherbrooke.ca
Always discuss trial participation with your own doctor first.
| Centre Hospitalier Universitaire de Sherbrooke (CHUS) | Sherbrooke, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05451251